Shaygannejad V - Search Results

1

Prevalence of multiple sclerosis in Isfahan, Iran.

Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F. Etemadifar M, et al. Among authors: shaygannejad v. Neuroepidemiology. 2006;27(1):39-44. doi: 10.1159/000094235. Epub 2006 Jun 27. Neuroepidemiology. 2006. PMID: 16804333

2

Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis.

Etemadifar M, Janghorbani M, Shaygannejad V. Etemadifar M, et al. Among authors: shaygannejad v. Acta Neurol Scand. 2006 May;113(5):283-7. doi: 10.1111/j.1600-0404.2006.00585.x. Acta Neurol Scand. 2006. PMID: 16629762 Clinical Trial.

3

Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.

Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V. Shaygannejad V, et al. Headache. 2006 Apr;46(4):642-8. doi: 10.1111/j.1526-4610.2006.00413.x. Headache. 2006. PMID: 16643559 Clinical Trial.

4

Conjugal multiple sclerosis in Isfahan, Iran: a population-based study.

Maghzi AH, Etemadifar M, Shaygannejad V, Saadatnia M, Salehi M, Hassanzadeh A. Maghzi AH, et al. Among authors: shaygannejad v. Mult Scler. 2007 Jun;13(5):673-5. doi: 10.1177/1352458506072092. Epub 2007 Feb 9. Mult Scler. 2007. PMID: 17548450

5

Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis.

Etemadifar M, Janghorbani M, Shaygannejad V. Etemadifar M, et al. Among authors: shaygannejad v. J Neurol. 2007 Dec;254(12):1723-8. doi: 10.1007/s00415-007-0637-1. Epub 2007 Dec 14. J Neurol. 2007. PMID: 18074075 Clinical Trial.

6

A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prophylaxis.

Ashtari F, Shaygannejad V, Akbari M. Ashtari F, et al. Among authors: shaygannejad v. Acta Neurol Scand. 2008 Nov;118(5):301-5. doi: 10.1111/j.1600-0404.2008.01087.x. Acta Neurol Scand. 2008. PMID: 18713156 Clinical Trial.

7

Effects of rivastigmine on memory and cognition in multiple sclerosis.

Shaygannejad V, Janghorbani M, Ashtari F, Zanjani HA, Zakizade N. Shaygannejad V, et al. Can J Neurol Sci. 2008 Sep;35(4):476-81. doi: 10.1017/s0317167100009148. Can J Neurol Sci. 2008. PMID: 18973065 Clinical Trial.

8

Short-term effects of prolonged fasting on multiple sclerosis.

Saadatnia M, Etemadifar M, Fatehi F, Ashtari F, Shaygannejad V, Chitsaz A, Maghzi AH. Saadatnia M, et al. Among authors: shaygannejad v. Eur Neurol. 2009;61(4):230-2. doi: 10.1159/000197108. Epub 2009 Jan 29. Eur Neurol. 2009. PMID: 19176964

9

Sensory complaints of the upper extremities in multiple sclerosis: relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation.

Chitsaz A, Janghorbani M, Shaygannejad V, Ashtari F, Heshmatipour M, Freeman J. Chitsaz A, et al. Among authors: shaygannejad v. Clin J Pain. 2009 May;25(4):281-5. doi: 10.1097/AJP.0b013e318190862b. Clin J Pain. 2009. PMID: 19590475 Clinical Trial.

10

Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?

Ashtari F, Fatehi F, Shaygannejad V, Chitsaz A. Ashtari F, et al. Among authors: shaygannejad v. Neurol Neurochir Pol. 2009 Sep-Oct;43(5):428-32. Neurol Neurochir Pol. 2009. PMID: 20054744 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters